MEDICAL FACILITIES CORP (DR.CA) Fundamental Analysis & Valuation

TSX:DR • CA58457V5036

Current stock price

17.06 CAD
+0.19 (+1.13%)
Last:

This DR.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

9

1. DR.CA Profitability Analysis

1.1 Basic Checks

  • In the past year DR was profitable.
  • DR had a positive operating cash flow in the past year.
  • Of the past 5 years DR 4 years were profitable.
  • DR had a positive operating cash flow in each of the past 5 years.
DR.CA Yearly Net Income VS EBIT VS OCF VS FCFDR.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M 80M

1.2 Ratios

  • The Return On Assets of DR (7.80%) is better than 84.62% of its industry peers.
  • The Return On Equity of DR (28.17%) is better than 100.00% of its industry peers.
  • DR's Return On Invested Capital of 19.99% is amongst the best of the industry. DR outperforms 100.00% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for DR is significantly above the industry average of 6.93%.
  • The last Return On Invested Capital (19.99%) for DR is above the 3 year average (17.04%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.8%
ROE 28.17%
ROIC 19.99%
ROA(3y)11.41%
ROA(5y)7.31%
ROE(3y)36.64%
ROE(5y)23.18%
ROIC(3y)17.04%
ROIC(5y)16.99%
DR.CA Yearly ROA, ROE, ROICDR.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

1.3 Margins

  • DR has a Profit Margin of 8.36%. This is amongst the best in the industry. DR outperforms 92.31% of its industry peers.
  • DR's Profit Margin has improved in the last couple of years.
  • DR has a better Operating Margin (18.36%) than 100.00% of its industry peers.
  • In the last couple of years the Operating Margin of DR has grown nicely.
  • DR has a Gross Margin of 69.88%. This is amongst the best in the industry. DR outperforms 100.00% of its industry peers.
  • DR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 18.36%
PM (TTM) 8.36%
GM 69.88%
OM growth 3Y8.16%
OM growth 5Y9.83%
PM growth 3YN/A
PM growth 5Y28.17%
GM growth 3Y1.88%
GM growth 5Y0.92%
DR.CA Yearly Profit, Operating, Gross MarginsDR.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. DR.CA Health Analysis

2.1 Basic Checks

  • DR has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • DR has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for DR has been reduced compared to 5 years ago.
  • The debt/assets ratio for DR is higher compared to a year ago.
DR.CA Yearly Shares OutstandingDR.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
DR.CA Yearly Total Debt VS Total AssetsDR.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

2.2 Solvency

  • Based on the Altman-Z score of 1.48, we must say that DR is in the distress zone and has some risk of bankruptcy.
  • DR has a better Altman-Z score (1.48) than 61.54% of its industry peers.
  • The Debt to FCF ratio of DR is 2.47, which is a good value as it means it would take DR, 2.47 years of fcf income to pay off all of its debts.
  • DR has a better Debt to FCF ratio (2.47) than 92.31% of its industry peers.
  • A Debt/Equity ratio of 1.18 is on the high side and indicates that DR has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 1.18, DR is in line with its industry, outperforming 46.15% of the companies in the same industry.
  • Even though the debt/equity ratio score it not favorable for DR, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 1.18
Debt/FCF 2.47
Altman-Z 1.48
ROIC/WACC2.55
WACC7.84%
DR.CA Yearly LT Debt VS Equity VS FCFDR.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

2.3 Liquidity

  • A Current Ratio of 1.79 indicates that DR should not have too much problems paying its short term obligations.
  • DR's Current ratio of 1.79 is amongst the best of the industry. DR outperforms 100.00% of its industry peers.
  • DR has a Quick Ratio of 1.70. This is a normal value and indicates that DR is financially healthy and should not expect problems in meeting its short term obligations.
  • DR has a Quick ratio of 1.70. This is amongst the best in the industry. DR outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.79
Quick Ratio 1.7
DR.CA Yearly Current Assets VS Current LiabilitesDR.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. DR.CA Growth Analysis

3.1 Past

  • DR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.96%, which is quite good.
  • Measured over the past years, DR shows a very strong growth in Earnings Per Share. The EPS has been growing by 41.82% on average per year.
  • DR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -23.34%.
  • The Revenue has been decreasing by -6.93% on average over the past years.
EPS 1Y (TTM)15.96%
EPS 3Y162.88%
EPS 5Y41.82%
EPS Q2Q%-16.95%
Revenue 1Y (TTM)-23.34%
Revenue growth 3Y-15.72%
Revenue growth 5Y-6.93%
Sales Q2Q%-17.54%

3.2 Future

  • DR is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.70% yearly.
  • DR is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -8.81% yearly.
EPS Next Y92.77%
EPS Next 2Y-20.43%
EPS Next 3Y3.7%
EPS Next 5YN/A
Revenue Next Year-21.82%
Revenue Next 2Y-10.47%
Revenue Next 3Y-8.81%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DR.CA Yearly Revenue VS EstimatesDR.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
DR.CA Yearly EPS VS EstimatesDR.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 1 1.5 2

More info and screens

Find the best growth stocksShow best growing peers

9

4. DR.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 11.45 indicates a reasonable valuation of DR.
  • 84.62% of the companies in the same industry are more expensive than DR, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 27.87, DR is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 5.94, the valuation of DR can be described as very cheap.
  • Based on the Price/Forward Earnings ratio, DR is valued cheaply inside the industry as 92.31% of the companies are valued more expensively.
  • The average S&P500 Price/Forward Earnings ratio is at 38.51. DR is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 11.45
Fwd PE 5.94
DR.CA Price Earnings VS Forward Price EarningsDR.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

  • DR's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. DR is cheaper than 100.00% of the companies in the same industry.
  • DR's Price/Free Cash Flow ratio is rather cheap when compared to the industry. DR is cheaper than 84.62% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.51
EV/EBITDA 4.4
DR.CA Per share dataDR.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • DR has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)0.12
PEG (5Y)0.27
EPS Next 2Y-20.43%
EPS Next 3Y3.7%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. DR.CA Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 2.13%, DR has a reasonable but not impressive dividend return.
  • DR's Dividend Yield is a higher than the industry average which is at 1.36.
  • Compared to an average S&P500 Dividend Yield of 1.81, DR has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.13%

5.2 History

  • The dividend of DR has a limited annual growth rate of 5.59%.
  • DR has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)5.59%
Div Incr Years0
Div Non Decr Years0
DR.CA Yearly Dividends per shareDR.CA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • DR pays out 23.95% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of DR is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP23.95%
EPS Next 2Y-20.43%
EPS Next 3Y3.7%
DR.CA Yearly Income VS Free CF VS DividendDR.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M
DR.CA Dividend Payout.DR.CA Dividend Payout, showing the Payout Ratio.DR.CA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

DR.CA Fundamentals: All Metrics, Ratios and Statistics

MEDICAL FACILITIES CORP

TSX:DR (4/17/2026, 7:00:00 PM)

17.06

+0.19 (+1.13%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)03-12
Earnings (Next)05-07
Inst Owners8.36%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap299.40M
Revenue(TTM)254.17M
Net Income(TTM)21.26M
Analysts42.22
Price Target16.58 (-2.81%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.13%
Yearly Dividend0.34
Dividend Growth(5Y)5.59%
DP23.95%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-31
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)21.13%
Min EPS beat(2)6.33%
Max EPS beat(2)35.92%
EPS beat(4)2
Avg EPS beat(4)2.44%
Min EPS beat(4)-24.98%
Max EPS beat(4)35.92%
EPS beat(8)3
Avg EPS beat(8)-21.58%
EPS beat(12)5
Avg EPS beat(12)-26.43%
EPS beat(16)7
Avg EPS beat(16)-104.25%
Revenue beat(2)1
Avg Revenue beat(2)-9.99%
Min Revenue beat(2)-21.89%
Max Revenue beat(2)1.91%
Revenue beat(4)1
Avg Revenue beat(4)-7.15%
Min Revenue beat(4)-21.89%
Max Revenue beat(4)1.91%
Revenue beat(8)2
Avg Revenue beat(8)-6.54%
Revenue beat(12)4
Avg Revenue beat(12)-4.25%
Revenue beat(16)4
Avg Revenue beat(16)-3.61%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)107.11%
EPS NY rev (3m)68.6%
Revenue NQ rev (1m)0.65%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-10.64%
Revenue NY rev (3m)-22.26%
Valuation
Industry RankSector Rank
PE 11.45
Fwd PE 5.94
P/S 0.86
P/FCF 5.51
P/OCF 4.91
P/B 2.9
P/tB N/A
EV/EBITDA 4.4
EPS(TTM)1.49
EY8.73%
EPS(NY)2.87
Fwd EY16.84%
FCF(TTM)3.1
FCFY18.16%
OCF(TTM)3.48
OCFY20.38%
SpS19.8
BVpS5.88
TBVpS-0.34
PEG (NY)0.12
PEG (5Y)0.27
Graham Number14.0382 (-17.71%)
Profitability
Industry RankSector Rank
ROA 7.8%
ROE 28.17%
ROCE 22.87%
ROIC 19.99%
ROICexc 25.4%
ROICexgc 50.53%
OM 18.36%
PM (TTM) 8.36%
GM 69.88%
FCFM 15.64%
ROA(3y)11.41%
ROA(5y)7.31%
ROE(3y)36.64%
ROE(5y)23.18%
ROIC(3y)17.04%
ROIC(5y)16.99%
ROICexc(3y)23.08%
ROICexc(5y)21.73%
ROICexgc(3y)54.96%
ROICexgc(5y)49%
ROCE(3y)19.49%
ROCE(5y)19.45%
ROICexgc growth 3Y4.72%
ROICexgc growth 5Y14.72%
ROICexc growth 3Y6.5%
ROICexc growth 5Y15.94%
OM growth 3Y8.16%
OM growth 5Y9.83%
PM growth 3YN/A
PM growth 5Y28.17%
GM growth 3Y1.88%
GM growth 5Y0.92%
F-Score5
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 1.18
Debt/FCF 2.47
Debt/EBITDA 1.43
Cap/Depr 31.15%
Cap/Sales 1.92%
Interest Coverage 9.31
Cash Conversion 71.63%
Profit Quality 187.05%
Current Ratio 1.79
Quick Ratio 1.7
Altman-Z 1.48
F-Score5
WACC7.84%
ROIC/WACC2.55
Cap/Depr(3y)47.39%
Cap/Depr(5y)41.2%
Cap/Sales(3y)3.17%
Cap/Sales(5y)2.64%
Profit Quality(3y)199%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.96%
EPS 3Y162.88%
EPS 5Y41.82%
EPS Q2Q%-16.95%
EPS Next Y92.77%
EPS Next 2Y-20.43%
EPS Next 3Y3.7%
EPS Next 5YN/A
Revenue 1Y (TTM)-23.34%
Revenue growth 3Y-15.72%
Revenue growth 5Y-6.93%
Sales Q2Q%-17.54%
Revenue Next Year-21.82%
Revenue Next 2Y-10.47%
Revenue Next 3Y-8.81%
Revenue Next 5YN/A
EBIT growth 1Y-10.18%
EBIT growth 3Y-8.84%
EBIT growth 5Y2.22%
EBIT Next Year-7%
EBIT Next 3Y-3.64%
EBIT Next 5YN/A
FCF growth 1Y-47.83%
FCF growth 3Y-7.53%
FCF growth 5Y-12.96%
OCF growth 1Y-46.4%
OCF growth 3Y-7.83%
OCF growth 5Y-12.51%

MEDICAL FACILITIES CORP / DR.CA Fundamental Analysis FAQ

What is the fundamental rating for DR stock?

ChartMill assigns a fundamental rating of 7 / 10 to DR.CA.


What is the valuation status of MEDICAL FACILITIES CORP (DR.CA) stock?

ChartMill assigns a valuation rating of 9 / 10 to MEDICAL FACILITIES CORP (DR.CA). This can be considered as Undervalued.


What is the profitability of DR stock?

MEDICAL FACILITIES CORP (DR.CA) has a profitability rating of 9 / 10.


What is the valuation of MEDICAL FACILITIES CORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for MEDICAL FACILITIES CORP (DR.CA) is 11.45 and the Price/Book (PB) ratio is 2.9.


How financially healthy is MEDICAL FACILITIES CORP?

The financial health rating of MEDICAL FACILITIES CORP (DR.CA) is 7 / 10.